Sumitomo Pharma America, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1984-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.sunovion.com
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
- Conditions
- Interventions
- First Posted Date
- 2011-10-24
- Last Posted Date
- 2014-05-15
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 847
- Registration Number
- NCT01458275
- Locations
- 🇺🇸
Dallas Allergy Immunology Research, Dallas, Texas, United States
🇺🇸Kerrville Research Associates, Kerrville, Texas, United States
🇺🇸San Jose Multispecialty Medical Group, Inc, Baldwin Park, California, United States
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
- Conditions
- Interventions
- First Posted Date
- 2011-10-13
- Last Posted Date
- 2014-05-06
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 848
- Registration Number
- NCT01451541
- Locations
- 🇺🇸
Sansum Clinic, Santa Barbara, California, United States
🇺🇸West Coast Clinical Trials, LLC, Costa Mesa, California, United States
🇺🇸National Allergy, Ashtma, and Urticaria Centers of Charleston, PA, North Charleston, South Carolina, United States
PEARL Schizophrenia Maintenance
- First Posted Date
- 2011-09-19
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 676
- Registration Number
- NCT01435928
- Locations
- 🇺🇸
Lousiana Clinical Research, LLC, Shreveport, Louisiana, United States
🇺🇸CRI Worldwide LLC, Willingboro, New Jersey, United States
🇺🇸FutureSearch Clinical Trials, LP, Dallas, Texas, United States
Major Depressive Disorder With Mixed Features
- Conditions
- Interventions
- First Posted Date
- 2011-08-25
- Last Posted Date
- 2012-12-13
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Registration Number
- NCT01423240
- Locations
- 🇺🇸
Montefiore Medical Center; Anxiety & Depression Clinic; Dept. of Psychiatry, Bronx, New York, United States
🇺🇸New Hope Clinical Research, Hickory, North Carolina, United States
🇺🇸Grayline Clinical Drug Trials, Wichita Falls, Texas, United States
Major Depressive Disorder With Mixed Features - Extension
- First Posted Date
- 2011-08-25
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT01423253
- Locations
- 🇺🇸
St. Charles Psychiatric Associates/Midwest Research Group, St. Charles, Missouri, United States
🇺🇸Village Clinical Research Inc., New York, New York, United States
🇺🇸Stanford -VA Palo Alto Health Care System, Palo Alto, California, United States
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
- Conditions
- Interventions
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2016-07-15
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 211
- Registration Number
- NCT01421134
- Locations
- 🇷🇸
Special Hospital for Psychiatric Diseases "Dr Slavoljub Bakalovic", Vrsac, Serbia
🇷🇸Special Hospital for Psychiatric Diseases "Sveti Vracevi", Vojvodina, Serbia
🇺🇸Clinical Innovations Inc., Riverside, California, United States
Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2013-04-30
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 327
- Registration Number
- NCT01401465
- Locations
- 🇺🇸
The Clinical Research Center, L.L.C., St. Louis, Missouri, United States
🇺🇸Clinical Research Institute of Southern Oregon, PC, Medford, Oregon, United States
🇺🇸Pharmacuetical Research & Consulting, Inc., Dallas, Texas, United States
Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis
- Conditions
- Interventions
- First Posted Date
- 2011-06-22
- Last Posted Date
- 2014-05-26
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT01378429
- Locations
- 🇺🇸
Sneeze, Wheeze, & Itch Associates, LLC, Normal, Illinois, United States
🇺🇸West Coast Clinical Trials, Costa Mesa, California, United States
🇺🇸Clinical Research Atlanta, Stockbridge, Georgia, United States
A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler
- Conditions
- Interventions
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2012-09-10
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT01371786
- Locations
- 🇬🇧
Quotient Clinical, Ruddington Fields, Ruddington, United Kingdom
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
- First Posted Date
- 2011-05-23
- Last Posted Date
- 2016-09-07
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 965
- Registration Number
- NCT01358357
- Locations
- 🇺🇸
AXIS Clinical Trials, Los Angeles, California, United States
🇺🇸Harmonex Neuroscience Research, Dothan, Alabama, United States
🇺🇸Behavioral Research Specialists, LLC, Glendale, California, United States